Indonesia At-Home Testing Kits Market - Industry Trends And Forecast To 2029

Indonesia at-home testing kits market is projected to register a CAGR of 4.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029
 

Market Segmentation: 
Indonesia At-home Testing Kits Market, By Test Type (Pregnancy Test Kits, Other At-Home Test Kits, Narcotic Test Kits, HIV Test Kits & Fertility Test Kits), Type of User (High Class, Middle Class & Lower Class), Type of Buyer (Pregnancy Test Kits, Other At-Home Test Kits, Narcotic Test Kits, HIV Test Kits & Fertility Test Kits), Process Location (At-Home & At-Home Lab Tests (Digital Results), Age (Adult, Geriatric & Pediatric), Brands (Pregnancy Test, Other At-Home Test, Narcotic Test, HIV Test, and Fertility Test), Distribution Channel (Institutional Buyer & Retail/Branded Sales) Industry Trends and Forecast to 2029
 

One of the major factor driving the market growth is:

• Rise in use of self-testing kits for the diagnosis of various diseases

Market Players:

The key market players for Indonesia at-home testing kits market are listed below:
• Abbott
• PT. Danpac Pharma 
• Orient Gene 
• Siemens Healthcare GmbH
• Medtronic 
• BD 
• B. Braun Melsungen AG 
• Quidel Corporation 
• NIPRO 
• F. Hoffmann-La Roche Ltd. 
• bioMérieux SA 
• EGENS GROUP
• DKT INTERNATIONAL 
• Clearblue (A subsidiary of SPD Swiss Precision Diagnostics GmbH) 
•  ACON Laboratories, Inc.